Insight Molecular Diagnostics Inc.
About
Insight Molecular Diagnostics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 26 2026
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
Mar 20 2026
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
Mar 13 2026
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
Mar 3 2026
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Feb 11 2026
iMDx Announces $26.0 Million Registered Direct Offering